The Amyotrophic Lateral Sclerosis Center: A Model of Multidisciplinary Management

Physical Medicine and Rehabilitation Clinics of North America

Volumn 19, Issue 3, 2008, Pages 619-631

  Mayadev, Angeli S ^a   Weiss, Michael D ^a   Jane Distad, B ^a   Krivickas, Lisa S ^b   Carter, Gregory T ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN; CANNABIS; DANTROLENE; DEXTROMETHORPHAN; ENEMA; FENTANYL; GABAPENTIN; HYDROXYZINE; LORAZEPAM; MORPHINE; MORPHINE SULFATE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PARACETAMOL; PSEUDOEPHEDRINE; QUINIDINE SULFATE; QUININE SULFATE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADL DISABILITY; AEROBIC EXERCISE; AMYOTROPHIC LATERAL SCLEROSIS; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ARTIFICIAL VENTILATION; BABINSKI REFLEX; BICYCLE; BLADDER AND BOWEL MANAGEMENT; CARDIOVASCULAR PERFORMANCE; CAREGIVER; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNICATION AID; CONDOM CATHETER; CONSTIPATION; COUNSELING; DAILY LIFE ACTIVITY; DEFECATION HABIT; DEPRESSION; DIAPER; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DYSARTHRIA; DYSPHAGIA; EMOTIONAL INCONTINENCE; EXERCISE; FATIGUE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HOFFMANN REFLEX; HOSPICE; HUMAN; HYPERSALIVATION; INTERPERSONAL COMMUNICATION; LIFE EXPECTANCY; LOADING DRUG DOSE; MEDICAL DECISION MAKING; MOOD CHANGE; MOTONEURON; MUSCLE CRAMP; MUSCLE TRAINING; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; ONSET AGE; ORTHOSIS; OVERALL SURVIVAL; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOBULBAR PALSY; PSYCHOTHERAPY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUALITY OF NURSING CARE; QUESTIONNAIRE; REHABILITATION CARE; REHABILITATION CENTER; RESPIRATION DEPRESSION; REVIEW; SEDATION; SHORT FORM 36; SIDE EFFECT; SOMNOLENCE; SPASTICITY; SPLINTING; STRETCHING EXERCISE; SUPPOSITORY; SURVIVAL RATE; SWIMMING POOL; TERMINAL CARE; UNSPECIFIED SIDE EFFECT; URINARY CATHETER; URINARY URGENCY; URINE INCONTINENCE; WALKING AID; WEAKNESS; WHEELCHAIR;

AMYOTROPHIC LATERAL SCLEROSIS; COMPREHENSIVE HEALTH CARE; DISEASE PROGRESSION; HUMANS; PATIENT CARE PLANNING; PATIENT CARE TEAM; TERMINAL CARE;

EID: 46749137186     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2008.04.004     Document Type: Review

References (45)

1. Van den Berg J.P., Kalmijn S., Lindeman E., et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 65 (2005) 1264-1267
2. Traynor B.J., Alexander M., Corr B., et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 74 (2003) 1258-1261
3. Trail M., Nelson N., Van J., et al. Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. Arch Phys Med Rehabil 82 1 (2001) 98-102
4. Abresch R.T., Seyden N.K., and Wineinger M.A. Quality of life: issues for persons with neuromuscular diseases. Phys Med Rehabil Clin N Am 9 1 (1998) 233-248
5. Carvalho M., Schwartz M.S., and Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve 18 (1995) 848-853
6. In: Brown R.H., Meininger V., and Swash M. (Eds). Amyotrophic lateral sclerosis (2000), Martin Duntz Ltd, London 412-413
7. Toepfer M., and Schroeder M. Delayed colonic transit times in amyotrophic later al sclerosis assessed with radio-opaque markers. Eur J Med Res 2 11 (1997) 473-476
8. Norris F., Sheperd R., Denys E., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118 1 (1993) 48-55
9. Mitsumoto H., Chad D.A., Pioro E.P., et al. Amyotrophic lateral sclerosis (1998), F.A. Davis, Philadelphia
10. Aitkens S.G., McCrory M.A., Kilmer D.D., et al. Moderate resistance exercise program: its effects in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74 7 (1993) 711-715
11. Kilmer D.D., McCrory M.A., Wright N.C., et al. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 75 5 (1994) 560-563
12. Dal Bello-Haas V., Florence J., Krivickas L.S., et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 68 23 (2003) 2003-2007
13. Kilmer D.D. The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am 9 1 (1998) 115-125
14. Carter G.T., and Miller R.G. Comprehensive management of amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 9 1 (1998) 271-284
15. Sharma K.R., Kent-Braun J.A., Majumdar S., et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 45 4 (1995) 733-740
16. Sharma K.R., and Miller R.G. Electrical and mechanical properties of skeletal muscle underlying increased fatigue in patients with amyotrophic lateral sclerosis. Muscle Nerve 19 (1996) 1391-1400
17. Okuda B., Kodama N., Kawabata K., et al. Corneomandibular reflex in ALS. Neurology 52 (1999) 1699-1701
18. McClelland S., Bethoux F., Boulis N.M., et al. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve 37 3 (2007) 396-398
19. Carter G.T., Johnson E.R., Bonekat H.W., et al. Laryngeal diversion in the treatment of intractable aspiration in motor neuron disease. Arch Phys Med Rehabil 73 7 (1992) 680-682
20. Miller R.G., Rosenberg J.A., Gelinas D.F., et al. Practice parameter: the care of patients with amyotrophic lateral sclerosis (an evidence-base review). Muscle Nerve 22 (1999) 1104-1111
21. Fried-Oken M., Fox L., Rau M.T., et al. Purposes of AAC device use for persons with ALS as reported by caregivers. Augment Altern Commun 22 3 (2006) 209-221
22. Kubler A., Nijboer F., Sidhu M., et al. Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface. Neurology 64 (2005) 1775-1777
23. Langmore S.E., Schatz M.A., and Olsen N. Fiberoptic endoscopic examination of swallowing safety: a new procedure. Dysphagia 2 (1988) 216-219
24. Brooks B.R., Thisted R.A., Appel S.H., et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 63 8 (2004) 1364-1370
25. Rosen H.J., and Cummeins J. A real reason for patients with pseudobulbar affect to smile. Ann Neurol 61 2 (2007) 92-96
26. Hunter M.D., Robinson I.C., and Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil 15 3 (1993) 119-126
27. Kurt A., and Nijboer F. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 21 4 (2007) 279
28. Meininger V. Breaking bad news in amyotrophic lateral sclerosis. Palliat Med 7 Suppl 4 (1993) 37-40
29. Amtmann D., Weydt P., Johnson K.L., et al. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 21 2 (2004) 95-104
30. Fields H.L. Relief of unnecessary suffering. In: Fields H.L., and Liebeskind J.C. (Eds). Pharmacologic approaches to the treatment of chronic pain: new concepts and critical issues vol. 1 (1994), International Association for the Study of Pain Press, Seattle (WA) 1-11
31. Ringel S.P., Murphy J.R., Alderson M.K., et al. The natural history of amyotrophic lateral sclerosis. Neurology 43 7 (1993) 1316-1322
32. Chancellor A.M., and Warlow C.P. Adult onset motor neuron disease: worldwide mortality, incidence, and distribution since 1950. J Neurol Neurosurg Psychiatry 55 12 (1992) 1106-1115
33. Neilson S., Robinson I., and Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 241 7 (1994) 448-455
34. Nelson L.M., McGuire V., Longstreth Jr. W.T., et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 151 2 (2000) 156-163
35. Nelson L.M., Matkin C., Longstreth Jr. W.T., et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol 151 2 (2000) 164-173
36. Bernat J.L. Ethical and legal issues in the management of amyotrophic lateral sclerosis. In: Belsh J.M., and Schiffman P.L. (Eds). Amyotrophic lateral sclerosis: diagnosis and management for the clinician (1996), Futura Publishing Co., Armonk (NY) 357-372
37. Carter G.T., Butler L.M., Abresch R.T., et al. Expanding the role of hospice in the care of amyotrophic lateral sclerosis. Am J Hosp Palliat Care 16 6 (1999) 707-710
38. Mitsumoto H., and Rabkin J.G. Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". JAMA 298 2 (2007) 207-216
39. Ganzini L., Johnston W.S., McFarland B.H., et al. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med 339 14 (1998) 967-973
40. Moore M.K. Dying at home: a way of maintaining control for the person with ALS/MND. Palliat Med 7 Suppl 4 (1993) 65-68
41. Oppenheimer E.A. Decision-making in the respiratory care of amyotrophic lateral sclerosis: should home mechanical ventilation be used?. Palliat Med 7 Suppl 4 (1993) 49-64
42. Veldink J.H., Wokke J.H., van der Wal G., et al. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N Engl J Med 346 21 (2002) 1638-1644
43. Krivickas L.S., Shockley L., and Mitsumoto H. Homecare of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci 152 Suppl 1 (1997) S82-S89
44. Standards and Accreditation Committee Medical Guidelines Task Force. Medical guidelines for determining prognosis in selected non-cancer diseases (1996), The National Hospice Organization p. 24-6
45. Enck R.E. Hospice: the next step. Am J Hosp Palliat Care 16 2 (1999) 436-437